Search clinical trials for: Indapamide

Total 42 results

Servier Russia

Not yet recruiting

Evaluation of the Antihypertensive effectIveness, Tolerability, and Adherence With Amlodipine/ Indapamide/ Perindopril Triple Single-pill Combination in Hypertensive Patients Without Concomitant Antihypertensive Therapy (TRIPTYCH) (TRIPTYCH)

Arterial Hypertension | HTN
Insel Gruppe AG, University Hospital Bern
University of Bern

Not yet recruiting

Indapamide and Chlorthalidone to Reduce Urine Supersaturation for Kidney Stone Prevention (INDAPACHLOR)

Kidney Stone

Switzerland
Pharmtechnology LLC

Recruiting

Bioequivalence Study of Perindopril /Amlodipine/Indapamide 8 mg (10 mg)/2.5 mg/10 mg Tablets in Healthy Volunteers Under Fasting Conditions

Bioequivalence

Russian Federation
Boryung Pharmaceutical Co., Ltd

Recruiting

A Study to Evaluate the Efficacy and Safety of BR1015 Combination Therapy

Essential Hypertension

Korea, Republic of
Centre for Chronic Disease Control, India
All India Institute of Medical Sciences, New Delhi; Imperial College London

Recruiting

Treatment Optimisation for Blood Pressure With Single-Pill Combinations in India (TOPSPIN)

Primary Hypertension

India
Ain Shams University

Not yet recruiting

Effect of Genetic Polymorphisms of UGT on the PKs of Indapamide in Egyptians (UGT/PKs)

Pharmacogenomics
Eastern Virginia Medical School

Recruiting

Reversal of Botulinum Neurotoxin Injection Related Dysphonia With Pyridostigmine

Dysphonia | Laryngeal Dystonia | Dysphonia, Spastic

United States
Brainfarma Industria Química e Farmacêutica S/A

Not yet recruiting

Efficacy and Safety Study of the Fixed-dose Combination of Olmesartan + Indapamide When Compared to the Isolated Drugs in the Treatment of Hypertension. (OLINDA)

Hypertension | Hypertension,Essential
University of Calgary

Recruiting

Hydroxychloroquine and Indapamide in SPMS

Multiple Sclerosis, Secondary Progressive

Canada
Shanghai Jiao Tong University School of Medicine

Recruiting

The Comparison Between Spironolactone and Indapamide Monotherapy or in Combination With Amlodipine to Reduce the Risk of Heart Failure (SIRRHF)

Hypertension

China
The George Institute
The University of New South Wales

Recruiting

Triple Therapy Prevention of Recurrent Intracerebral Disease EveNts Trial (TRIDENT)

Hypertension | Intracerebral Haemorrhage (ICH)

United Kingdom, Australia, Singapore, Georgia, Netherlands, Nigeria, Sri Lanka, Switzerland, Brazil, Malaysia, Taiwan, Vietnam
George Medicines PTY Limited

Completed

Efficacy and Safety of GMRx2 Compared to Dual Combinations for the Treatment of Hypertension (GMRx2_ACT)

Hypertension

Australia, United States, United Kingdom, Poland, Sri Lanka, New Zealand, Czechia
Alnylam Pharmaceuticals

Active, not recruiting

Zilebesiran as Add-on Therapy in Patients With Hypertension Not Adequately Controlled by a Standard of Care Antihypertensive Medication (KARDIA-2) (KARDIA-2)

Hypertension

United States, Canada, Latvia, Poland, United Kingdom, Germany, Lithuania, Estonia, Puerto Rico
George Medicines PTY Limited

Completed

Efficacy and Safety of GMRx2 Compared to Placebo for the Treatment of Hypertension (GMRx2_PCT)

Hypertension

Australia, United States, Nigeria, Sri Lanka, United Kingdom
Institut de Recherches Internationales Servier

Completed

Efficacy and Safety of Perindopril 5 mg / Indapamide 1.25 mg / Amlodipine 5 mg Fixed Combination in Hypertension

Hypertension

China
EMS

Suspended

Comparison of Losartan Associated With Indapamide Versus Hyzaar® in the Hypertension Treatment

Hypertension

Brazil
EMS

Withdrawn

Efficacy and Safety of Leningrado Association in the Treatment of Hypertension

Arterial Hypertension
Darnitsa Pharmaceutical Company
International Pharmaceutical Research Center

Completed

Bioequivalence Study of 8 mg Perindopril Tert-Butylamine / 2.5 mg Indapamide / 10 mg Amlodipine Tablets Versus 10 mg Perindopril Arginine / 2.5 mg Indapamide / 10 mg Amlodipine Film-Coated Tablets in Healthy Volunteers

Healthy Subjects | Bioequivalence

Jordan
Darnitsa Pharmaceutical Company
International Pharmaceutical Research Center

Completed

Bioequivalence Study of 8 mg Perindopril Tert-butylamine / 2.5 mg Indapamide Tablets Versus 10 mg Perindopril Arginine / 2.5 mg Indapamide Film-coated Tablets in Healthy Volunteers

Healthy Subjects | Bioequivalence

Jordan
Belfast Health and Social Care Trust
University of Toronto; Queen's University, Belfast

Completed

Role of Active Deresuscitation After Resuscitation-2 (RADAR-2)

Sepsis | Critical Illness | Trauma

United Kingdom
Boryung Pharmaceutical Co., Ltd

Completed

A Clinical Trial to Evaluate Drug-drug Interactions and Safety Between "BR1015-1" and "BR1015-2" in Healthy Volunteers

Hypertension

Korea, Republic of
Servier Russia

Completed

The Use of TrIple Fixed-dose Combination in the Treatment of Arterial Hypertension (TRICOLOR)

Arterial Hypertension

Russian Federation
The George Institute
University of Sydney

Terminated

Triple Therapy Prevention of Recurrent Intracerebral Disease EveNts Trial Magnetic Resonance Imaging Sub-study (TRIDENT-MRI)

Stroke | Hypertension | Cerebral Small Vessel Diseases | Vascular Dementia | Intracerebral Hemorrhage

Australia
University of Utah
Boston University; University of Pennsylvania; Northwestern University; Columbia... and other collaborators

Completed

ACEI or ARB and COVID-19 Severity and Mortality in US Veterans

Hypertension | COVID

United States
The George Institute
University of Sydney

Terminated

Triple Therapy Prevention of Recurrent Intracerebral Disease EveNts Trial (TRIDENT) Cognitive Sub-Study (TRIDENT COG)

Hypertension | Cerebral Small Vessel Diseases | Dementia, Vascular | Stroke Hemorrhagic | Cognitive Decline | Intracerebral Hemorrhage

Australia, Netherlands
EMS

Withdrawn

Efficacy and Safety of Leningrado 5 Association in the Treatment of Hypertension

Arterial Hypertension
Ahn-Gook Pharmaceuticals Co.,Ltd

Unknown

Phase III Study to Evaluate the Efficacy and Safety of AGSAVI in Patients With Essential Hypertension

Hypertension
KRKA
University Medical Centre Ljubljana; Clinres Farmacija d.o.o.

Completed

Management of Newly Diagnosed and Uncontrolled Hypertension With Fixed-Dose Combination of Perindopril/Amlodipine and Perindopril/Indapamide/Amlodipine (PRECIOUS)

Hypertension

Armenia, Croatia, Hungary, Poland, Russian Federation, Serbia, Slovenia
National University of Ireland, Galway, Ireland

Suspended

Coronavirus (COVID-19) ACEi/ARB Investigation (CORONACION)

COVID-19 | Hypertension

Ireland
Boryung Pharmaceutical Co., Ltd

Completed

Fimasartan in the Senior Subjects (FITNESS)

The Elderly (≥ 70 Years) With Essential Hypertension

Korea, Republic of
Peking University Third Hospital
Peking University; University of Michigan

Unknown

Spironolactone Versus Indapamide in Obese and Hypertensive Patients

Hypertension

China
Yaounde Central Hospital
University of Yaounde 1

Completed

Short-term Effects of Perindopril-amlodipine Versus Perindopril-indapamide in Type 2 Diabetes

Hypertension | Diabetes Mellitus, Type 2

Cameroon
Military Institute of Medicine, Poland

Completed

Non-invasive Haemodynamic Assessment in Hypertension (FINE-PATH)

Arterial Hypertension

Poland
Servier Hellas Pharmaceuticals Ltd.

Completed

Study for the Recording of Adherence to Treatment With Perindopril/Indapamide/Amlodipine Fixed Dose Combination (CONTROL-3)

Hypertensive Disease | Adherence to Medication Regime

Greece
University of Roma La Sapienza

Unknown

Low-dose Combination of Three Antihypertensive Drugs (3D)

Arterial Hypertension

Italy
University of Roma La Sapienza

Unknown

Once-daily Fixed Combination of Three Antihypertensive Drugs (ONE&ONLY)

Arterial Hypertension

Italy
West China Hospital

Completed

Indapamide Versus Hydrochlorothiazide in Elderly Hypertensive Patients With Renal Insufficiency

Hypertension | Renal Insufficiency

China
Hospices Civils de Lyon

Completed

IDEAL Study: Identification of the Determinants of the Efficacy of Arterial Blood Pressure Lowering Drugs

Hypertension

France
LaborMed Pharma S.A.

Completed

A Comparison of Indapamide SR 1.5 mg With HCTZ 25 mg, in Combination With an ACE-inhibitor, in Patients With Mild to Moderate AHT and Type 2 DM (AISHA)

Hypertension | Type 2 Diabetes Mellitus

Romania
University of Vigo
Hospital Clinico Universitario de Santiago; Xunta de Galicia; Ministerio de Educacion...

Completed

Ambulatory Blood Pressure Monitoring in the Prediction of Cardiovascular Events and Effects of Chronotherapy (MAPEC)

Hypertension

Spain
The George Institute
National Health and Medical Research Council, Australia; University of Sydney; Institut de Recherches Internationales Servier

Completed

Blood Pressure and Glucose Lowering for the Prevention of Vascular Disease in High Risk Patients With Type 2 Diabetes

Diabetes Mellitus, Type 2

Australia, Canada, China, Netherlands, United Kingdom
Imperial College London
British Heart Foundation; Institut de Recherches Internationales Servier

Unknown

The Hypertension in the Very Elderly Trial (HYVET)

Hypertension

United Kingdom, Bulgaria, China, Finland, Romania, Russian Federation

Search clinical trials for: Indapamide

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Albania

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations